亿欧大健康3月19日讯,以岭药业今日对外发布公告称,其全资子公司以岭万洲向美国FDA申报的伐昔洛韦片的新药简略申请已获得批准,接下来以岭万洲可以生产并在美国市场销售该产品。
据悉,伐昔洛韦主要用于治疗带状疱疹、单纯疱疹病毒感染、预防(抑制)单纯疱疹病毒感染的复发。伐昔洛韦片由葛兰素史克公司研发,于1995年在美国上市。当前,美国境内伐昔洛韦片的主要生产厂商有Sandoz,Mylan 、Teva等。伐昔洛韦片美国市场2018年度销售额约为1.86亿美元。
上一篇:东易日盛2019年营收38亿元,净亏损1.8亿元
下一篇:京新药业拟斥1.2亿元在山东潍坊投建原料药生产基地
prevArticle
nextArticle
newDetail
comment
hotnews
t
d
k
obLevel
__env
app
device
isMobile
errors
__empty_1
__currentLoopData
loop
hotnewsVal
select * from `news` where `news`.`id` = '66334' and `news`.`deleted_at` is null limit 1
SELECT *
LIMIT
ORDER BY
select * from `new_cates` where `new_cates`.`id` in ('62') and `new_cates`.`deleted_at` is null
select * from `news` where `news`.`deleted_at` is null order by `browse` desc limit 10
update `news` set `browse` = `browse` + 1, `updated_at` = '2025-08-24 07:46:16' where `id` = '66334' and `news`.`deleted_at` is null
select * from `news` where `id` < '66334' and `newscate_id` = '62' and `news`.`deleted_at` is null order by `id` desc limit 1
select * from `news` where `id` > '66334' and `newscate_id` = '62' and `news`.`deleted_at` is null order by `id` asc limit 1
select * from `comments` where `news_id` = '66334'